Table 3.
Proportion of unit-pairs with a significant cross correlation
| Drug | OFC |
OFC |
||||
|---|---|---|---|---|---|---|
| Base | Early | Late | Base | Early | Late | |
| VEH | 0.17 | 0.25 | 0.25 | 0.17 | 0.38 | 0.45 |
| DOI 1.0 | 0.31 | 0.20 | 0.20 | 0.30 | 0.12 | 0.12 |
| DOI 3.0 | 0.14 | 0.18 | 0.24 | 0.24 | 0.23 | 0.19 |
| DOI 5.0 | 0.23 | 0.24 | 0.23 | 0.13 | 0.15 | 0.17 |
| MK | 0.28 | 0.21 | 0.23 | 0.27 | 0.25 | 0.28 |
| AMP | 0.26 | 0.20 | 0.22 | 0.21 | 0.11 | 0.22 |
The proportion of OFC (left group of columns) and ACC (right group of columns) unit-pairs classified as having a significant cross-correlation in discharge are listed in the baseline, early, and late postinjection period.